The investor's view
- Five fundamentals, each ranked against the all covered companies
- A peer map of growth against margin
- Where the profit is made

Premiums cover the costs; investments earn the profit
Q2 FY2026, the quarter to Jun 30, 2026 · 10-Q filed Aug 7, 2026
Benefits and expenses used 96.0% of earned premiums, so investment income of $984M carried nearly all pretax earnings.
In the quarter, total benefits and expenses were $3.12B against net earned premiums of $3.25B: 96.0% of premiums, compared with 96.2% a year earlier. Net investment income was $984M, equal to 98.9% of earnings before income taxes of $995M and to 30.3% of earned premiums.1
The filing calls investment income one of the drivers of the company's profitability. It invests primarily in fixed maturity securities to provide a reliable stream of income, matched to the cash flows its policy liabilities require. Reserves build in a policy's early years because, in the filing's words, claims payments are expected to gradually increase over the life of a policy.1
A year earlier, net investment income of $1.08B was 131.5% of pretax earnings of $822M, because net investment losses of $421M absorbed part of it. This quarter those losses were $153M. The filing ties the lower investment income to lower call income, lower floating rate income and the weaker yen.1
AnalysisAnalysis: the split is partly a matter of presentation. The benefit line includes the growth of reserves that the investment income exists to fund, so underwriting and investing are two halves of one pricing decision. What the ratio shows is dependence on yield: a change in what the portfolio earns reaches pretax earnings with little to cushion it.
Japan's premiums in force fell to $7.2B in dollars while the U.S. grew to $6.8B, closing most of last year's gap.
Aflac Japan's annualized premiums in force, translated at period-end exchange rates, were $7.2B at the end of June against $8.2B a year earlier. Aflac U.S. annualized premiums in force rose to $6.8B from $6.5B. The U.S. figure equals 94.4% of Japan's, against 79.3% a year earlier.1
The filing names three causes for Japan: a weaker yen, which reports fewer dollars for the same yen business; older limited-pay policies reaching premium paid-up status; and an external reinsurance transaction. Aflac Japan's premium persistency slipped to 92.7% from 93.7%. For the U.S., the filing credits improved sales and continued strong persistency, 79.4% against 79.2%.1
Japan still brings in more revenue. Aflac Japan's adjusted revenues of $2.16B equalled 52.5% of total revenues in the quarter, against $1.77B, or 43.0%, for Aflac U.S., and the filing describes Aflac Japan as the principal contributor to consolidated earnings.1
AnalysisAnalysis: much of the narrowing is currency, which can move either way, and premiums in force are not profit. The U.S. book renews less of its premium each year and its group products carried higher claims this quarter. The shift still changes how the company reads: a growing share of its premium base now sits outside the yen.
Have a question about Aflac? Ask CXProWealth on ChatGPT.Free membership required.
Where Aflac stands among its peers, ten years of growth and cash, where the profit is made, and the edge and the risks.
How Aflac's model works step by step, where every $100 of revenue goes against the industry, and how long it took to scale.
Revenue went from $15.4B in FY2007 to $17.2B in FY2025, over 18 years.
Member research, then your own questions on ChatGPT.
What Aflac's numbers depend on from here, read from the filing: the conditions behind this period's margins and growth, and where a change would show first.
The assumptions, yields and loan credit this quarter's profit rests on, and which signals would show them changing first.
What currency does to the premium base, the earnings and the cash sent to the parent, separated from the insurance itself.
Loading…
Explore its competitive edge, where the profit is made, the trends and the risks, with CXProWealth on ChatGPT.
Business Lens describes Aflac from its own filings with the SEC. It is not a view on its shares, a target, or advice to buy, sell or hold anything; figures are as filed and may be restated by the company later. The filing, the dates and the version are under the financial data above.